Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

The family of Henrietta Lacks settles lawsuit with Novartis over use of her cells, marking a turning point in fight for accountability and justice.

Amatera’s approach is “2x faster and 10x more cost-effective” than industry standards for developing new varieties of perennials, it claims.

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

California-based solar EV developer Aptera Motors has built the first vehicle on its validation assembly line. The company ...

JNARDDC advances indigenous metallurgical technologies to reduce India's import dependence, enhancing quality control and ...

Dedifferentiated liposarcoma lacks effective IGF-1→PPAR-γ adipogenic signaling due to epigenetic silencing of PPAR-γ2, with ...

PHCbi will exhibit LiCellGrow™ at the 25th Congress of the Japanese Society for Regenerative Medicine, March 19-20 at the Kobe International Conference Center and Kobe International Exhibition Center ...

Operator: Good day, and welcome to the Solid Power Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] ...

Konstanz, a leading global institute for applied photovoltaic (PV) research, today announced a strategic partnership with Celloraa Energy through MoU, to support the ramp-up of 1.2 GW of ...

AB Science says a newly identified blood biomarker may help assess masitinib activity in its ongoing Phase 3 ALS clinical ...

US battery developer Lyten has announced the completion of its acquisition of Northvolt Ett and Ett Expansion (Skellefteå, ...